Nordson Corporation (NASDAQ:NDSN) continues to be a popular option among institutional investors, owning 79% of the company. Nordson reported a record fourth quarter and fiscal year 2025 results. Several noteworthy financial advisories and asset management firms, including Harbor Capital Advisors, Gradient Investments, and Curi Capital, have significant stakes in Nordson, underscoring investor confidence. The company's Q4 earnings exceeded estimates, displaying strong EPS growth and margin-resilient performance. Nordson managed to weather sales expectations miss by having a high performing share price and the recent Q4 earnings beat has fortified confidence in its 2026 Outlook. Amid these developments, Baird has maintained its neutral recommendation for Nordson, highlighting the company's mixed signals and modest return potential. The company continues to reward its shareholders, having completed a divestiture of select manufacturing products and focusing on proprietary medical components.
Nordson Corp NDSN News Analytics from Sat, 08 Mar 2025 08:00:00 GMT to Thu, 01 Jan 2026 18:22:33 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor 5
